View this email in your browser Kia ora and welcome the February edition of the Healthtech Activator (HTA) Monthly Wrap.Following a strong start to the year, momentum across Aotearoa’s healthtech ecosystem continued through February. This month brought a mix of research funding developments and del
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

View this email in your browser

HealthTech Activator banner


Kia ora and welcome the February edition of the Healthtech Activator (HTA) Monthly Wrap.


Following a strong start to the year, momentum across Aotearoa’s healthtech ecosystem continued through February. This month brought a mix of research funding developments and delivery progress across the health system that are directly relevant to founders, clinicians and partners working to translate innovation into impact.


Research funding and translation signals


At a national level, the announcement of the inaugural Research Funding New Zealand board signals a shift toward more coordinated and strategic research investment. Of relevance for the healthtech sector is the inclusion of Distinguished Professor Sir Peter Hunter, alongside Professor Brett Cowan, whose work spans clinical health sciences and biomedical engineering, and Dr Meika Foster, who brings experience bridging applied science, commercialisation and impact. Together, this mix of expertise reflects a growing focus on connecting research, digital health innovation, and translation into real-world health system outcomes.


Digital health and community-led innovation


February also highlighted strong momentum in digital health, particularly where technology is being shaped by lived experience and frontline insight. This month, HTA launched its new Digital Health page, accompanied by several initiatives that highlight how digital tools are being shaped for practical, real-world application. The Diabetes New Zealand Research Foundation announced recipients of its inaugural small-grant round, supporting initiatives such as the LIFT digital app for rangatahi living with diabetes, alongside digitally enabled research into culturally responsive diabetes care for Chinese and South Asian communities. In parallel, aged care facilities began adopting a world-leading digital Deterioration Early Warning System developed in New Zealand, supporting earlier recognition of clinical deterioration and more timely intervention. Together, these examples reflect a growing emphasis on digital health solutions that are practical, context-aware, and outcomes-focused.


Progress was also evident in the digital foundations of care delivery. February updates to the GP2GP programme showed steady improvements in the reliability of electronic patient record transfers between general practices. Recent patient management system releases are reducing transfer errors and strengthening interoperability across primary care.


HTA capability highlight: In-depth support


To support founders navigating this evolving landscape, HTA continues to provide in-depth, hands-on capability support. Through one-to-one advisory sessions and access to specialist tools and databases, HTA works with teams to move beyond high-level assumptions and build evidence-led strategies that stand up to scrutiny from customers, investors and health system decision-makers.


Alongside this, the HTA Directory profiles organisations and capabilities across the ecosystem, helping increase visibility and connect founders with partners, investors and the health system.


If you are building, validating or scaling a healthtech solution, explore HTA’s capability support or get in touch to see how we can help.

Upcoming HTA workshops


Build to Scale Series


HTA’s Build to Scale Series is now underway, sharing practical insights for healthtech teams navigating the transition from validation to scale. The series explores topics such as evidence generation, readiness, and adoption within real world health system contexts.


A dedicated webpage bringing the full collection of videos together is coming soon. In the meantime, videos are rolling out on LinkedIn over the coming weeks. Follow HTA to stay up to date as the series continues.

QMS Corner: ISO 13485 Learning Series


Q3 – Risk & Efficiency Focus


Quarter 3 of the QMS Learning Series is now underway, with a focus on embedding risk and efficiency into ISO 13485–aligned quality management systems in a way that supports real-world delivery and scale.


This quarter focuses on:

  • Lean, risk-based approaches to ISO 13485 implementation
  • Using risk to scale documentation, controls, and oversight
  • Reducing QMS complexity without compromising compliance

Latest Article: Simplifying ISO 13485 Compliance: Lean Approaches to QMS Implementation


This article explores why ISO 13485 so often feels complex in practice, and how a lean, risk-based approach can help organisations focus control where it matters most. It outlines practical ways to use risk as the organising principle of a QMS, enabling teams to meet regulatory expectations while avoiding unnecessary paperwork and friction.


Coming soon on 3 March: How to Turn ISO 13485 Compliance Into a Competitive Advantage – From Burden to Strategic Asset. Keep an eye on the QMS webpage for the full article.


Upcoming webinar:

Driving Quality Forward: Risk and Efficiency Strategies for ISO 13485 Success

24 March 2026, 11am - 12pm, Online


This session will explore how to apply risk-based thinking to build efficient, scalable QMS processes that support both compliance and business outcomes.

REGISTER HERE

Additional Q3 resources, including a quiz and whitepaper, will be released throughout the quarter.

Health Economics Workshop

18 March 2026, 9am – 3pm, Auckland


Understand the drivers and processes used to determine economic value and a health system’s willingness to pay for a healthcare product. This highly interactive workshop is intended for decision-makers and organisations wanting to systematically compare technologies, access new markets, and secure reimbursement strategies across several healthcare environments and systems.


The workshop is co-produced with Te Tītoki Mataora and led by Abbas Al-Murrani - Managing Director & Founder, Health Economics Consulting NZ.

REGISTER HERE

NZ Sector Events

News

NZ News

With samples taken from patients, Dr Hossein Jahedi is building a collection of tiny, fleshy lumps of cancer. Photo: Supplied / University of Auckland

  • 'Excitement' over potential for testing cancer drugs on lab-grown tumours at Auckland Uni
  • NZ start-up launches AI app for lifetime health records
  • Pharmac proposing two new therapies for adults with leukemia
  • New medicine funding could be life-saving for rural areas, health expert says
  • Could cancer actually protect against Alzheimer’s disease?

World News

  • FDA Launches a Digital Health Devices Pilot
  • AI in Medical Devices: Safety Questions the Industry Can’t Afford to Ignore

Mā te wā,


HealthTech Activator team

Callaghan Innovation


Was this email forwarded to you? You can subscribe to future emails on the HTA website. For regular updates and insights follow the HealthTech Activator on LinkedIn.

 

Callaghan Innovation; 69 Gracefield Road, Gracefield, Lower Hutt, 5010